Biping Deng

Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial

Jing Pan, Yue Tan, Guoling Wang et al. · Journal of Clinical Oncology · 2021 · 280 citations

CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia

Jing Pan, Qing Niu, Biping Deng et al. · Leukemia · 2019 · 242 citations · Full text

High efficacy and safety of low-dose CD19-directed CAR-T cell therapy in 51 refractory or relapsed B acute lymphoblastic leukemia patients

Jing Pan, Jieyu Yang, Biping Deng et al. · Leukemia · 2017 · 231 citations

Hematological Malignancy, Cell Therapy, Oncology +6

Corticosteroids do not influence the efficacy and kinetics of CAR-T cells for B-cell acute lymphoblastic leukemia

Shuangyou Liu, Biping Deng, Zhichao Yin et al. · Blood Cancer Journal · 2020 · 151 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Cell Therapy +8

Combination of <scp>CD19</scp> and <scp>CD22 CAR‐T</scp> cell therapy in relapsed B‐cell acute lymphoblastic leukemia after allogeneic transplantation

Shuangyou Liu, Biping Deng, Zhichao Yin et al. · American Journal of Hematology · 2021 · 119 citations · Full text